Since July 2020 Bridges Consulting has kindly provided pro bono consultancy support to EURACAN upon agreement with the ERN’s coordinator and members.
Managing Director, Steve Bridges, is based in Brussels and he advises and supports advocacy so that European policy makers understand the value of EURACAN for rare cancer patients in the European Union. Steve has over fifteen years of experience in supporting medical societies, patient groups, industry and associations to effectively reach policy makers and stakeholders with their message. He is delighted to work with EURACAN towards a better future for patients with rare cancer in Europe.
We are currently working together to try and ensure that EURACAN is considered under the new upcoming funding framework of the EU, and the landmark Beating Cancer Plan.